Literature DB >> 21210727

Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma.

Marieta I Toma1, Thomas Weber, Matthias Meinhardt, Stefan Zastrow, Marc-Oliver Grimm, Susanne Füssel, Manfred P Wirth, Gustavo B Baretton.   

Abstract

Expression of FOXP1 and Ki67 was immunohistochemically assessed on tissue microarrays of 129 cases of clear cell renal cell carcinomas. Overall and disease-specific survival correlated inversely with pT-category, grading and lymph node metastasis in (p < .05). Expression of FOXP1 correlated negatively with tumor grading (p = .02), but neither with pT-category nor with lymph node metastasis. Significant positive correlation was shown for Ki67 expression and tumor stage and lymph node metastasis (p < .05). The overall survival and the disease-specific survival correlated negatively with the Ki67 status (p < .05). FOXP1 expression negatively correlated with Ki67 expression in clear cell renal cell carcinomas (p = .036).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210727     DOI: 10.3109/07357907.2010.535059

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  11 in total

1.  Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.

Authors:  Xia Yan; Huiling Zhou; Tingting Zhang; Pan Xu; Shusen Zhang; Wei Huang; Linlin Yang; Xingxing Gu; Runzhou Ni; Tianyi Zhang
Journal:  Tumour Biol       Date:  2015-07-06

2.  FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging.

Authors:  Hanjun Li; Pei Liu; Shuqin Xu; Yinghua Li; Joseph D Dekker; Baojie Li; Ying Fan; Zhenlin Zhang; Yang Hong; Gong Yang; Tingting Tang; Yongxin Ren; Haley O Tucker; Zhengju Yao; Xizhi Guo
Journal:  J Clin Invest       Date:  2017-02-27       Impact factor: 14.808

Review 3.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

4.  Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma.

Authors:  Jinbo Song; Zhe Yu; Bingqi Dong; Mingkai Zhu; Xiaofeng Guo; Yongkang Ma; Shiming Zhao; Tiejun Yang
Journal:  World J Surg Oncol       Date:  2021-05-25       Impact factor: 2.754

5.  Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.

Authors:  Liancheng Zhu; Zhenhua Hu; Juanjuan Liu; Jian Gao; Bei Lin
Journal:  Med Oncol       Date:  2014-12-11       Impact factor: 3.064

6.  FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.

Authors:  Eun Jung Choi; Eun Jin Seo; Dae Kyoung Kim; Su In Lee; Yang Woo Kwon; Il Ho Jang; Ki-Hyung Kim; Dong-Soo Suh; Jae Ho Kim
Journal:  Oncotarget       Date:  2016-01-19

7.  Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.

Authors:  Yali Song; Xiaoling Li; Zhaoyang Zeng; Qiao Li; Zhaojian Gong; Qianjin Liao; Xiayu Li; Pan Chen; Bo Xiang; Wenling Zhang; Fang Xiong; Yanhong Zhou; Ming Zhou; Jian Ma; Yong Li; Xiang Chen; Guiyuan Li; Wei Xiong
Journal:  Oncotarget       Date:  2016-06-14

8.  Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.

Authors:  Zhun Wang; Hui Xie; Linpei Guo; Qiliang Cai; Zhiqun Shang; Ning Jiang; Yuanjie Niu
Journal:  Cancer Manag Res       Date:  2017-11-21       Impact factor: 3.989

Review 9.  The untold stories of the speech gene, the FOXP2 cancer gene.

Authors:  Maria Jesus Herrero; Yorick Gitton
Journal:  Genes Cancer       Date:  2018-01

10.  Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients.

Authors:  Tian Zhang; Sarabjot Pabla; Felicia L Lenzo; Jeffrey M Conroy; Mary K Nesline; Sean T Glenn; Antonios Papanicolau-Sengos; Blake Burgher; Vincent Giamo; Jonathan Andreas; Yirong Wang; Wiam Bshara; Katherine G Madden; Keisuke Shirai; Konstantin Dragnev; Laura J Tafe; Rajan Gupta; Jason Zhu; Matthew Labriola; Shannon McCall; Daniel J George; Pooja Ghatalia; Farshid Dayyani; Robert Edwards; Michelle S Park; Rajbir Singh; Robin Jacob; Saby George; Bo Xu; Matthew Zibelman; Razelle Kurzrock; Carl Morrison
Journal:  Oncoimmunology       Date:  2020-06-10       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.